TK007 phase II study final analysis. Genetically modified donor lymphocytes abate transplant related mortality and increase leukaemia-free survival providing early immune reconstitution after haploidentical haematopoietic stem cell transplantation

Stanghellini MTL;CICERI, FABIO;BONINI , MARIA CHIARA;BONDANZA , ATTILIO;Traversari C;Toma S;Salomoni M;Turchetto L;Colombi S;Bernardi M;Peccatori J;Pescarollo A;Servida P;Magnani Z;Perna SK;Valtolina V;Crippa F;Callegaro L;Spoldi E;Fleischhauer K;PONZONI , MAURILIO;Vago L;Santoro A;Todisco E;Apperley J;Slavin S;Weissinger E;Hertenstein B;Bregni M;Stampino CG;Bruzzi P;BORDIGNON, CLAUDIO

2008-01-01